Skip to main content

Table 5 Prognostic factors for overall survival

From: Preoperative Master’s double two-step test may predict survival after lobectomy in patients with lung cancer

Variable

Univariate analysis

p value

Multivariate analysis

p value

Risk ratio (95% CI)

Risk ratio (95% CI)

Male

2.55 (1.47–4.65)

 < 0.001

1.15 (0.39–3.44)

0.807

Age

1.10 (1.06–1.14)

 < 0.001

1.08 (1.03–1.12)

 < 0.001

PS 1, 2

6.58 (1.59–18.1)

0.014

1.59 (0.34–5.29)

0.514

Smoking history

2.33 (1.35–4.19)

0.002

1.49 (0.51–4.54)

0.476

CCI

1.34 (1.20–1.46)

 < 0.001

1.20 (1.04–1.35)

0.013

Incomplete MDT

3.48 (1.92–6.32)

 < 0.001

2.05 (1.00–4.02)

0.049

CEA level

1.07 (1.04–1.10)

 < 0.001

1.06 (1.03–1.09)

0.003

SUV max

1.08(1.03–1.12)

0.002

0.99 (0.92–1.07)

0.844

Invasive component size

1.07 (1.04–1.11)

 < 0.001

1.04 (0.99–1.10)

0.083

Non-adenocarcinoma

2.48 (1.47–4.11)

 < 0.001

0.91 (0.41–1.99)

0.811

Lymphatic invasion

1.17 (0.35–2.88)

0.771

  

Vascular invasion

1.68 (0.41–4.57)

0.420

  

STAS

1.08 (0.53–2.00)

0.814

  
  1. CI: confidence interval, PS: performance status, CCI: Charlson comorbidity index, MDT: Master’s double two-step test, CEA: carcinoembryonic antigen, SUV: standardized uptake value, STAS: spread through air spaces